Dr. Sahin presented our recent work on how we take genome/transcriptome-wide approaches to identify regulators of drug resistance, identify mechanisms of resistance and develop novel drug candidates on Feb 12, 2021 at the Seminar Series of Izmir Biomedicine and Genome Center (IBG), which is a leading biomedical center in Turkey.
Dr. Sahin released statements to the MUSC press about our work. Here is the press release: https://hollingscancercenter.musc.edu/news/archive/2022/10/07/hollings-recruits-researcher-who-targets-aggressive-breast-cancer
Our latest article has been published in Cell Death & Differentiation. The study focuses on the molecular mechanism of Transforming Acidic Coiled-Coil Containing Protein 3 (TACC3) in highly aggressive breast tumors with Centrosome amplification (CA). Read more…
0 Comments